Doximity Investor Day Presentation Deck
CORE MODULE PORTFOLIO
We create
customized
packages for
customers
doximity
9:41
<
Sponsored by PharmaCo
Take a Closer Look at New
Phase 3 Data for Doxlera®
(doxilimubab)
Sponsored
The once daily inhalation mist of Doxlera®
showed significant reduction in COPD
exacerbations (flare ups).
In a 24-week study, patients living with chronic
obstructive pulmonary disease COPD went
through a program with Doxlera® (doxilimumab)
and showed significant results.
Doxlera inhalation mist helps maintain the
daily management and treatment of airflow
obstruction in patients living with COPD.
all?
Significant Reduction in Rate of COPD
Exacerbations with Doxlera®
Annual Rate of COPD Exacerbations
News
O
Search
Dialer
Fax/Mog
PI
Long Form
91
Cangers
9:41
0:22
Doxleraumati
7
Doxlera (doxilimubab)
6 colleagues viewed
Once-weekly DOXLERA significantly
improved moderate-to-severe COPD
exacerbation rates with a
demonstrated safety profile.
4
Add a comment
wp
O
Learn More About Doxlera (doxilimumab) and its
Mechanism of Action
News
As opposed to other treatments in its field, Doxlera® is unique in the
fact that it can help its patients take control of their health ...more
5
INDICATION AND IMPORTANT SAFETY INFORMATION
Doxiera (daxilimumab) is indicated as an adjunct to standard
treatment for chronic obstructive pulmonary disease (COPD)
The Washington Post
2d
Q
Search
Med Guide
all
C
Dialer
Sponsored
23% REDUCTION
Fax/Mag
Video
Prescribing Info
Careers
9:41
a
G
Doxlera® (doxilimubab)
6 colleagues read
4
6.0
Add a comment
16 ₁
Discover How Doxlera Is Changing the Way Physicians
Approach Medicine
Doxiera works differently than most medicines in its field by
directly encapsulating, binding, and inactivating abnormal
Ω
INDICATION AND IMPORTANT SAFETY INFORMATION
Doxiera (doxilimumab) is indicated as an adjunct to standard
treatment for chronic obstructive pulmonary disease (COPD)
Ca
News
The Guardian
2d
Search
all?
Med Guide
C 19
Dialer
Sponsored
Fax/Msg
JD
Prescribing Info
Short Form
Careers
DOCS Investor Day - June 6, 2023View entire presentation